People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus
Register for this webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour
Test will be available at NHS laboratories across the UK, using its ARCHITECT i1000SR and i2000SR and Alinity i laboratory instruments
Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity
Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers
A qualitative test for the detection of nucleic acid from SARS-CoV-2
The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.
Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement
The digital tool could help simplify the screening, diagnosis and monitoring of patients with respiratory compromise in the current COVID-19 pandemic
The cutting-edge technology is utilized to aid drug development and medical equipment production
Mass production comes as part of a nationwide effort to support the NHS in the fight against COVID-19
The Alinity m molecular laboratory COVID-19 test instrument claims it can run up to 1,080 tests in 24 hours
The real-time PCR system aims to accelerate coronavirus research and diagnostics
Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11
AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines
Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients
Innovosens building partnerships to accelerate development, testing and market launch
The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe
The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment
Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.
Collaboration will enable global development, manufacturing and distribution of the vaccine
Comprehensive turnkey system based on LabVantage LIMS platform allows laboratories to implement COVID-19 Biobanking, testing and research
The combination of the unique technologies aims to bring a novel angle to combat the global pandemic
Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease
